Overview

A Pilot Study for the Evaluation of Minocycline as a Microglia Inhibitor in the Treatment of Diabetic Macular Edema

Status:
Completed
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to investigate the safety and efficacy of minocycline as a microglia inhibitor in individuals with diabetic macular edema (DME).
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
National Eye Institute (NEI)
Collaborators:
The Emmes Company, LLC
The EMMES Corporation
Treatments:
Minocycline